We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Risk of Contamination Reduced During Blood Culture Collection

By Labmedica staff writers
Posted on 28 Jul 2008
Print article
A newly developed kit provides a safer and easier process for blood culture collection that can help minimize contamination.

Blood cultures are critical in the early detection stage for sepsis--a severe, whole-body immune response to infection. Sepsis is a serious condition, which is caused by microbes or their toxins in blood or tissues. The new kit minimizes the risk of false-positive results from the lab, which can be expensive for both patients and hospitals.

The new WorkSafe blood culture kit includes BacT/Alert three-dimensional (3D) blood culture bottles, made of a multi-layer polycarbonate instead of glass, which decreases the risk of breakage and blood or body fluid exposures. This improves worker and patient safety by limiting the amount of potential exposure to biohazardous materials. The lightweight plastic bottles can be sent through pneumatic transportation tube systems without custom holders.

Launched by bioMérieux (Marcy l'Etoile, France), the kit is a key element of the company's WorkSafe campaign that equips hospital workers with one simple kit with all necessary components for safe and efficient blood culture-collection. The kit eliminates the need for nurses or phlebotomists to manually pull loose and disparate pieces together for blood culture collection. The kit also contains a disposal bag for all biohazardous materials.

bioMérieux provides diagnostic solutions (reagents, instruments, software), which determine the source of disease and contamination to improve patient health and ensure consumer safety. The products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies, and cancer screening and monitoring. They are also used for detecting microorganisms in agri-food, pharmaceutic, and cosmetic products.


Related Links:
bioMérieux
New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.